ATE534389T1 - Bisbenzimidazole und mittel gegen malaria - Google Patents

Bisbenzimidazole und mittel gegen malaria

Info

Publication number
ATE534389T1
ATE534389T1 AT08835050T AT08835050T ATE534389T1 AT E534389 T1 ATE534389 T1 AT E534389T1 AT 08835050 T AT08835050 T AT 08835050T AT 08835050 T AT08835050 T AT 08835050T AT E534389 T1 ATE534389 T1 AT E534389T1
Authority
AT
Austria
Prior art keywords
bisbenzimidazole
relates
present
antimalaria drugs
antimalaria
Prior art date
Application number
AT08835050T
Other languages
English (en)
Inventor
Eynde Jean Jacques Vanden
Aurelie Pietka
Tien Huang
Annie Mayence
Original Assignee
Univ Mons Hainaut
Xavier University Of Louisiana
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Mons Hainaut, Xavier University Of Louisiana filed Critical Univ Mons Hainaut
Application granted granted Critical
Publication of ATE534389T1 publication Critical patent/ATE534389T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT08835050T 2007-10-05 2008-10-02 Bisbenzimidazole und mittel gegen malaria ATE534389T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07117987 2007-10-05
PCT/EP2008/063224 WO2009043902A1 (en) 2007-10-05 2008-10-02 Bisbenzimidazoles as antimalarial agents

Publications (1)

Publication Number Publication Date
ATE534389T1 true ATE534389T1 (de) 2011-12-15

Family

ID=39469502

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08835050T ATE534389T1 (de) 2007-10-05 2008-10-02 Bisbenzimidazole und mittel gegen malaria

Country Status (4)

Country Link
US (1) US20100160402A1 (de)
EP (1) EP2194981B1 (de)
AT (1) ATE534389T1 (de)
WO (1) WO2009043902A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7906655B2 (en) * 2008-08-07 2011-03-15 Bristol-Myers Squibb Company Hepatitis C virus inhibitors

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES467739A1 (es) * 1977-03-16 1979-07-01 Hoechst Ag Procedimiento para la preparacion de compuestos de bisbenci-midazolil sustituidos
US5204352A (en) * 1987-09-29 1993-04-20 The United States Of America As Represented By The Secretary Of The Army Compounds exhibiting anti-parasitic activity and a method for their use
US5373005A (en) * 1988-04-20 1994-12-13 Merrell Dow Pharmaceuticals Inc. Despiramine in the treatment of drug-resistant malarial infections
US5428051A (en) * 1992-10-13 1995-06-27 University Of North Carolina Methods of combating pneumocystis carinii pneumonia and compounds useful therefor
WO1995008540A1 (en) * 1993-09-22 1995-03-30 The Wellcome Foundation Limited Bis(amidinobenzimidazolyl)alkanes as antiviral agents
US5643935A (en) * 1995-06-07 1997-07-01 The University Of North Carolina At Chapel Hill Method of combatting infectious diseases using dicationic bis-benzimidazoles
US5723495A (en) * 1995-11-16 1998-03-03 The University Of North Carolina At Chapel Hill Benzamidoxime prodrugs as antipneumocystic agents
US5942532A (en) * 1997-09-05 1999-08-24 Ortho Pharmaceutical Corporation 2-substituted phenyl-benzimidazole antibacterial agents
AU770656B2 (en) * 1998-09-17 2004-02-26 Duke University Antifungal activity of dicationic molecules
DE19853944A1 (de) * 1998-11-24 2000-05-25 Bourdichon Alain Jacques Verwendung von Diminazen-di-aceturat zur Behandlung von Malaria
AU779923B2 (en) * 1999-07-08 2005-02-17 Georgia State University Novel prodrugs for antimicrobial amidines
US6569853B1 (en) * 2000-11-06 2003-05-27 Combinatorx, Incorporated Combinations of chlorpromazine and pentamidine for the treatment of neoplastic disorders
WO2006021833A2 (en) * 2003-11-25 2006-03-02 University Of Cincinnati Bisbenzamidines for the treatment of pneumonia
CA2559208A1 (en) * 2004-03-17 2005-09-29 Mpex Pharmaceuticals, Inc. Use and administration of bacterial efflux pump inhibitors
WO2008070831A2 (en) * 2006-12-07 2008-06-12 Xavier University Of Louisiana Bisbenzamidines and bisbenzamidoximes for the treatment of human african trypanosomiasis

Also Published As

Publication number Publication date
EP2194981A1 (de) 2010-06-16
WO2009043902A1 (en) 2009-04-09
US20100160402A1 (en) 2010-06-24
EP2194981B1 (de) 2011-11-23

Similar Documents

Publication Publication Date Title
EA201000777A1 (ru) Ингибиторы репликации вируса иммунодефицита человека
CY1118344T1 (el) Αναστολεις απομεθυλασης-1 ειδικης για λυσινη και η χρηση αυτων
CY1116754T1 (el) Παραγωγα νιτροκατεχολης ως αναστολεις της comt
MA32544B1 (fr) Derives de pyridino-pyridinones, leur preparation et leur application en therapeutique
MX352161B (es) Cinta adhesiva resistente a la abrasión.
TW200942533A (en) Pyridyl inhibitors of hedgehog signalling
WO2009026179A3 (en) Antiinfective proanthocyanidin compounds and methods of use thereof
NZ592425A (en) Isoindoline compounds for use in the treatment of cancer
TW201129565A (en) Tricyclic heterocyclic compounds, compositions and methods of use thereof
MX2009009290A (es) Compuestos activos en ppar.
IN2012DN01233A (de)
MX2009005881A (es) Derivados de 2-(piperidin-4-il)-4-fenoxi o fenilamino-pirimidina como inhibidores de la transcriptasa inversa no nucleosida.
MX2010010406A (es) Tetrahidrofenantridinonas y tetrahidrociclopentaquinolinonas como inhibidores de la polimerizacion de poli(adp-ribosa)polimerasa-1 y tubulina.
TW200736233A (en) Cyclohexyl piperazinyl methanone derivatives
EA201200189A1 (ru) Фуразанобензимидазолы в качестве пролекарств для лечения опухолевых или аутоиммунных заболеваний
TW200942535A (en) Novel compounds as cannabinoid receptor ligands
TR201908514T4 (tr) İlaç doz aşimi tedavi̇si̇ i̇çi̇n morfi̇nan türevleri̇
MX340714B (es) Inhibidores de hsp90.
DK1919466T3 (da) Formuleringer til behandling af lipoprotein-abnormiteter omfattende et statin og et methylnicotinamidderivat
MA32727B1 (fr) Pyrazolylaminopyridines au titre d'inhibiteurs de fak
MX2012006805A (es) Indolil-piperidinil bencilaminas como inhibidores de beta-triptasa.
CY1111168T1 (el) Παραγωγο βενζιμιδαζολιου και χρηση αυτου
WO2006097617A3 (fr) Nouveaux derives dihydropyrimidines et leur utilisation comme agents anti-cancereux
MX2011011764A (es) Compuestos de carboxamida y su uso como inhibidores de calpaina.
UA107675C2 (en) N-(4-((3-(2-amino-4-pyrimidinyl)-2-pyridinyl)oxy)phenyl)-4-(4-methyl-2-thienyl)-1-phthalazinamine for use in the treatment of antimitotic agent resistant cancer